Skip to main content
Janmeet Anant on Muck Rack

Janmeet Anant

As seen in: BioProcess International Magazine, Pharmaceutical Online, Bioprocess Online, Outsourced Pharma, Pharma's Almanac, Cell & Gene, Biosimilar Development, Advancing RNA
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Janmeet

Contact Janmeet, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Aseptic Process Sampling Risk Mitigation – A Regulatory Perspective

|
By Janmeet Anant, Marc-Antoine Kaag
| Advancing RNA
By Janmeet Anant, Regulatory Advocate, Marc-Antoine Kaag, Global Product Manager, Sampling There are significant consequences associated with microbial contamination during biopharmaceutical manufacturing. Contamination increases risks for the operator, the company, and potentially the patient, all of which can result in significant negative impact.
Open in Who Shared Issue with article?

05.21.26 -- Minimizing Regulatory Risk For Biologics Manufacturing Changes

|
By Janmeet Anant, Marc-Antoine Kaag
| Biosimilar Development Verified
Aseptic Process Sampling Risk Mitigation – A Regulatory Perspective This overview outlines regulatory guidelines for sampling, examines the limitations of conventional methods, and emphasizes the advantages of aseptic, single-use approaches in achieving compliance. Let's take a closer look at the current electronic quality management system (eQMS) landscape in pharma/biotech and what a future-ready eQMS must enable to support continuous improvement.
Open in Who Shared Issue with article?

04.23.25 -- Understanding EU Regulatory Requirements In Cell Therapy Clinical Trials

|
By Jessica Cordes, Ana Marques Kuschel, Janmeet Anant, Ayan Dey
| Cell & Gene Verified
Webinar: Mastering the Complexities of Gene Therapy Document Writing Gene therapy is complex—and so is writing about it. From viral vectors to cell types, every element demands deep understanding. Safety reporting adds further complexity: is an adverse event from chemotherapy, a procedure, or the gene therapy itself? These challenges require a thoughtful, flexible approach to document strategy and execution.
Open in Who Shared Issue with article?
See all 14 articles